In June 2021, RedCloud Bio secured investment of RMB 100 million in a Series B financing led by Co-Win Ventures, participated by Kaitai Capital. Sherpa Healthcare Partners, Dayou Capital and Dynamic BalanceInvestment Management also contributed to the Series B round.
In November 2019, The Company received a Series A financing from Dayou Capital and Sherpa Healthcare Partners.
Contact Us
Taizhou |Building 6, 2 Xiejiashe Road, Medical High-Tech Industrial Development Zone
Beijing |5th Floor, Central Laboratory Building, No. 38 Xueyuan Road
Website: https://www.redcloudbio.com